Financials
Financial year 2025
TereLabs from Brussel, company number BE1004932767, closed financial year 2025 with a result of € 61,199 after tax. For that financial year TereLabs recorded a gross margin of € 83,807 and equity of € 162,315. Compared with financial year 2024, the result moved from € 96,116 to € 61,199. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 162,315
▲ 61% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 61,199
▼ 36% vs 2024
Profit after tax over the fiscal year.
€ 134,339
▲ 54% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 157,315.
People and assets in 2025
€ 14,147
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,922
▼ 65% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,914
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 128,397 | € 83,807 | ▼ 35% |
| Profit after taxes | € 96,116 | € 61,199 | ▼ 36% |
| Equity | € 101,116 | € 162,315 | ▲ 61% |
| Total debts | € 59,918 | € 45,422 | ▼ 24% |
| Cash | € 86,988 | € 134,339 | ▲ 54% |
| Retained profit | € 96,116 | € 157,315 | ▲ 64% |
| Balance sheet total | € 161,034 | € 207,737 | ▲ 29% |
By gross margin, TereLabs ranks 7th of 7 companies with main activity “Speur- en ontwikkelingswerk op biotechnologisch gebied” in Brussel that publish figures (fiscal year 2025).
Key figures of TereLabs, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about TereLabs the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to TereLabs?
What happened at TereLabs in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 61,199 (▼ 36% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
In short
From € 96,116 profit in 2024 to € 61,199 profit in 2025.
Paid € 41,809 in corporate taxes since 2024.
Best year ever: 2024, with € 96,116 profit.
Establishments
Establishment units
Physical locations of this company
Wolstraat 21 box 4
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 12 active companies in Brussel, largest first.
CENTRE D'ETUDE ET DE TRAITEMENT EN OPHTALMOLOGIE
€ 1.8 million gross margin · 2025
€ 744,185 gross margin · 2025
Innovation In Research & Engineering Solutions
€ 555,368 gross margin · 2025
€ 230,403 gross margin · 2025
Centre for Advanced Research & Development
€ 163,556 gross margin · 2025
€ 153,810 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- MACIAS OCHOA Paulo Cesar(oprichter) 100%
Details
- Company number
- 1004.932.767
- VAT number
- BE 1004.932.767
- Registered office
- Wolstraat 21 bus 4, 1000 Brussel
- Names & denominations
- TereLabs
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 2024
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied